Human internal mammary artery responses to non-peptide vasopressin antagonists.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 8039263)

Published in Clin Exp Pharmacol Physiol on February 01, 1994

Authors

J J Liu1, P A Phillips, L M Burrell, B B Buxton, C I Johnston

Author Affiliations

1: Department of Cardiac Surgery, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia.

Articles by these authors

Reduced thirst after water deprivation in healthy elderly men. N Engl J Med (1984) 3.13

Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas (2004) 2.85

Chronic heart failure in Australian general practice. The Cardiac Awareness Survey and Evaluation (CASE) Study. Med J Aust (2001) 2.71

Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation (1998) 1.87

Getting new evidence into medicine. Med J Aust (2000) 1.79

Vegetarian diet: panacea for modern lifestyle diseases? QJM (1999) 1.68

Developmental expression of ACE2 in the SHR kidney: a role in hypertension? Kidney Int (2006) 1.68

Passive ventricular constraint amends the course of heart failure: a study in an ovine model of dilated cardiomyopathy. Cardiovasc Res (1999) 1.65

Global longitudinal strain is a strong independent predictor of all-cause mortality in patients with aortic stenosis. Eur Heart J Cardiovasc Imaging (2012) 1.63

Evidence from cross circulation studies for a humoral mechanism in the natriuresis of saline loading. Proc Soc Exp Biol Med (1966) 1.61

Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells. Gastroenterology (2000) 1.55

Cross-circulation experiments on the mechanism of the natriuresis during saline loading in the dog. Circ Res (1967) 1.55

Direct vasodilator effect of milrinone, an inotropic drug, on arterial coronary bypass grafts. FANZCA . J Thorac Cardiovasc Surg (1997) 1.53

Hospitals and hospitalists: an alternative view. Internal Medicine society of Australia and New Zealand. Med J Aust (1999) 1.42

Cardiac risk factor management. Experience of an outpatient hypertension clinic. Med J Aust (1991) 1.40

Plasma atrial natriuretic peptide in patients with acute myocardial infarction: effects of streptokinase. Br Heart J (1989) 1.39

Diffuse tumor microembolism: a rare cause of a high-probability perfusion scan. Chest (1997) 1.39

Influence of food on the bioavailability of a sustained-release verapamil preparation. J Pharm Sci (1990) 1.38

Comparison of angiotensin converting enzyme inhibitors captopril and MK421-diacid in guinea pig atria. Eur J Pharmacol (1982) 1.35

Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension. Lancet (1979) 1.34

Angiotensin receptors: distribution, signalling and function. Clin Sci (Lond) (2001) 1.27

Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut (2005) 1.23

Atrial natriuretic peptide in chronic heart failure in the rat: a correlation with ventricular dysfunction. Circ Res (1986) 1.23

Reduced osmotic thirst in healthy elderly men. Am J Physiol (1991) 1.20

Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis. Am J Pathol (1999) 1.19

Occupational upper extremity disorders in the federal workforce. Prevalence, health care expenditures, and patterns of work disability. J Occup Environ Med (1998) 1.18

Chronic obstructive jaundice induced by Reovirus type 3 in weanling mice. Pathology (1969) 1.15

Angiotensin-converting enzyme inhibitors in the treatment of hypertension. Drugs (1984) 1.15

Swapping health care systems. Whose grass is really greener? JAMA (1996) 1.15

Vitamin A inhibits pancreatic stellate cell activation: implications for treatment of pancreatic fibrosis. Gut (2005) 1.10

Aging and disturbances of thirst and fluid balance. Nutr Rev (1990) 1.06

Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression. Exp Physiol (2008) 1.05

Isolation of renin granules from rat kidney cortex and evidence for an inactive form of renin (prorenin) in granules and plasma. Endocrinology (1976) 1.03

Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7/MAS-1-dependent pathways. Am J Physiol Renal Physiol (2010) 1.03

A comparison of chlorothiazide, chlorthalidone and cyclopenthiazide in the treatment of hypertension. Med J Aust (1973) 1.02

Radioimmunoassay for plasma antidiuretic hormone. J Endocrinol (1972) 1.02

Pancreatic stellate cell activation by ethanol and acetaldehyde: is it mediated by the mitogen-activated protein kinase signaling pathway? Pancreas (2003) 1.01

Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients. Clin Sci (Lond) (1981) 1.00

Correlation between angiotensin converting enzyme inhibition and the acute hypotensive response to MK 421 in essential hypertension. Clin Exp Pharmacol Physiol Suppl (1982) 0.99

Renin substrate in granules from rat kidney cortex. Biochem J (1976) 0.99

Metabolism of angiotensin II in sodium depletion and hypertension in humans. Circ Res (1972) 0.99

Vasopressin in circulatory control and hypertension. J Hypertens (1985) 0.98

Enalapril (MK421) activation in man: importance of liver status. Br J Clin Pharmacol (1985) 0.98

Association of genital adenovirus infection with urethritis in men. Med J Aust (1984) 0.98

Contribution of vasopressin to the maintenance of blood pressure during dehydration. Am J Physiol (1983) 0.97

Localization of vasopressin binding sites in rat tissues using specific V1 and V2 selective ligands. Endocrinology (1990) 0.97

The relationship of plasma levels of pindolol in hypertensive patients to effects on blood pressure, plasma renin and plasma noradrenaline levels. Clin Exp Pharmacol Physiol (1975) 0.96

Neurohumoral responses to chronic myocardial infarction in rats. Circulation (1988) 0.95

Renin, angiotensin II, and adrenal corticosteroid relationships during sodium deprivation and angiotensin infusion in normotensive and hypertensive man. Circ Res (1972) 0.95

Adenovirus type 19 and a closely related new serotype in genital infection. Br J Vener Dis (1982) 0.95

Inhibition of adenylate cyclase by angiotensin II in rat renal cortex. Endocrinology (1982) 0.95

Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists. Am J Med (1989) 0.95

Localization of endothelin receptors in rat kidney. Eur J Pharmacol (1989) 0.94

Plasma renin levels and vascular complications in hypertension. Br Med J (1973) 0.94

Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition. J Hypertens Suppl (1983) 0.94

Acute renal haemodynamic and renin-angiotensin system responses to graded renal artery stenosis in the dog. J Physiol (1979) 0.94

Viral meningitis due to echovirus types 6 and 9: epidemiological data from Western Australia. Epidemiol Infect (1996) 0.93

Clinical management of carpal tunnel syndrome: a 12-year review of outcomes. Am J Ind Med (1999) 0.93

Chronotropic effects of angiotensin I, angiotensin II, bradykinin and vasopressin in guinea pig atria. Eur J Pharmacol (1982) 0.92

Angiotensin converting enzyme inhibition in renovascular hypertension: frequency of reversible renal failure. Lancet (1984) 0.92

Treatment of hypertension with angiotensin converting enzyme inhibitors. Clin Exp Pharmacol Physiol Suppl (1982) 0.92

Use of captopril in the diagnosis of renal hypertension. Aust N Z J Med (1981) 0.91

Vasopressin V1 and V2 receptors in diabetes mellitus. Am J Physiol (1994) 0.91

Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels. Am J Cardiol (1982) 0.91

Hydrocephalus in mice inoculated neonatally by the oronasal route with reovirus type 1. Science (1970) 0.91

Altered water excretion in healthy elderly men. Age Ageing (1987) 0.90

Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients. Clin Exp Pharmacol Physiol (1981) 0.90

Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension. Br J Clin Pharmacol (1984) 0.90

A review of plasma renin measurements and their clinical significance. Aust N Z J Med (1971) 0.90

Increased cardiac angiotensin-converting enzyme in rats with chronic heart failure. Clin Exp Pharmacol Physiol (1990) 0.90

Effect of aging on regional cerebral blood flow responses associated with osmotic thirst and its satiation by water drinking: a PET study. Proc Natl Acad Sci U S A (2007) 0.90

Decreased cardiac beta-adrenergic receptors in deoxycorticosterone-salt and renal hypertensive rats. Circ Res (1979) 0.90

Biological significance of renin angiotensin immunization. Circ Res (1970) 0.90

Immunoreactive arginine-vasopressin in Brattleboro rat ovary. Nature (1984) 0.89

Osmotic thirst and vasopressin release in humans: a double-blind crossover study. Am J Physiol (1985) 0.89

Second Australian National Blood Pressure Study (ANBP2). Australian Comparative Outcome Trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council of Australia. Clin Exp Hypertens (1997) 0.89

Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition. Kidney Int (1981) 0.88

Identification, distribution, and expression of angiotensin II receptors in the normal human prostate and benign prostatic hyperplasia. Endocrinology (2001) 0.88

Localization of angiotensin converting enzyme in rat heart. Circ Res (1991) 0.88

Susceptibility to atrial fibrillation: a study in an ovine model of pacing-induced early heart failure. J Cardiovasc Electrophysiol (1998) 0.88

Inhibition of adenylate cyclase in rat adrenal glomerulosa cells by angiotensin II. Endocrinology (1984) 0.88

Review article: the pathophysiological roles of the renin-angiotensin system in the gastrointestinal tract. Aliment Pharmacol Ther (2012) 0.87

Restoration of suppressed baroreflex sensitivity in rats with hereditary diabetes insipidus (Brattleboro rats) by arginine-vasopressin and DDAVP. Circ Res (1983) 0.87

Effects of deoxycorticosterone on plasma renin acitivity in conscious dogs. Am J Physiol (1969) 0.87

Emergency treatment of severe hypertension with intravenous labetalol. Med J Aust (1978) 0.87

Osmoregulation of thirst and vasopressin release in severe chronic renal failure. Kidney Int (1991) 0.87

Relation of plasma renin to sodium balance and arterial pressure in experimental renal hypertension. Circ Res (1966) 0.87

Controlled trial of enalapril in congestive cardiac failure. Br Heart J (1985) 0.87

Role of vasopressin in hypertension: studies using the Brattleboro rat. Am J Physiol (1982) 0.87

Acute angiotensin II-mediated restoration of distal renal artery pressure in renal artery stenosis and its relationship to the development of sustained one-kidney hypertension in conscious dogs. Hypertension (1980) 0.86

In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartan. Am J Hypertens (2000) 0.86

Body fluid changes, thirst and drinking in man during free access to water. Physiol Behav (1984) 0.86

The contribution of vasopressin and angiotensin to the maintenance of blood pressure after autonomic blockade. Hypertension (1985) 0.86

Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy. Diabetologia (2003) 0.86

Lisinopril pharmacokinetics in chronic renal failure. Br J Clin Pharmacol (1988) 0.85

Cortical activation and lamina terminalis functional connectivity during thirst and drinking in humans. Am J Physiol Regul Integr Comp Physiol (2011) 0.85

Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia. J Pathol (2001) 0.85